MIF and obesity due to melanocortin 4 receptor deficiency: Here, we investigated the potential of T. spiralis-derived MIF as a modulator of obesity and evaluated its feasibility as a novel anti-obesity therapeutic candidate with fewer adverse effects by targeting the immune–metabolic axis.